Amyloid-Beta Peptides and Activated Astroglia Impairs Proliferation of Nerve Growth Factor Releasing Cells In Vitro: Implication for Encapsulated Cell Biodelivery-Mediated AD Therapy

Alzheimer’s disease (AD) treatment is constrained due to the inability of peripherally administered therapeutic molecules to cross the blood–brain barrier. Encapsulated cell biodelivery (ECB) devices, a tissue-targeted approach for local drug release, was previously optimized for human mature nerve...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Sumonto Mitra, Silvia Turchetto, Winant Van Os, Lars U. Wahlberg, Bengt Linderoth, Homira Behbahani, Maria Eriksdotter
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	MDPI AG 2021-10-01
Seri Bilgileri:	Cells
Konular:	Alzheimer’s disease (AD) astrocytes amyloid beta (Aβ) encapsulated cell biodelivery (ECB) nerve growth factor (NGF) drug delivery strategy optimization
Online Erişim:	https://www.mdpi.com/2073-4409/10/11/2834
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!